From: Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
Gene
Sensitivity
Specificity
ASB2
0.631
0.914
ETNK2
0.797
0.943
KCNJ15
0.778
0.886
MEIS2
0.839
0.829
NRG1
0.619
0.971
NTN1
0.749
0.771
NUDT10
0.787
0.743
PDE4A
0.759
SRPX
0.73
0.714